234 related articles for article (PubMed ID: 29485359)
1. Influence of ionizing radiation on the antimicrobial activity of the antibiotics sulfamethoxazole and trimethoprim.
Sági G; Szabacsi K; Szabó L; Homlok R; Kovács K; Mohácsi-Farkas C; Pillai SD; Takács E; Wojnárovits L
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2018 Jul; 53(8):687-693. PubMed ID: 29485359
[TBL] [Abstract][Full Text] [Related]
2. Decomposition of sulfamethoxazole and trimethoprim by continuous UVA/LED/TiO
Cai Q; Hu J
J Hazard Mater; 2017 Feb; 323(Pt A):527-536. PubMed ID: 27324695
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ
Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
[TBL] [Abstract][Full Text] [Related]
4. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
Murray BE; Rensimer ER; DuPont HL
N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
6. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
Rosenblatt JE; Stewart PR
Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
[TBL] [Abstract][Full Text] [Related]
7. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.
Greenwood D; O'Grady F
J Clin Pathol; 1976 Feb; 29(2):162-6. PubMed ID: 777036
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
Rawal BD; Cottis L
Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
[TBL] [Abstract][Full Text] [Related]
10. Removal of trimethoprim, sulfamethoxazole, and triclosan by the green alga Nannochloris sp.
Bai X; Acharya K
J Hazard Mater; 2016 Sep; 315():70-5. PubMed ID: 27179202
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial Assessment of Heteroaryl, Vinyl, Benzyl, and Alkyl Tetrazole Compounds.
Dudley J; Feinn L; DeFrancesco H; Lindsay E; Coca A; Roberts EL
Med Chem; 2018; 14(6):550-555. PubMed ID: 29165091
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
13. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Vilchèze C; Jacobs WR
Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Unal S; Aydin M; Akin A
Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the antibacterial activity of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
Legler F
Arzneimittelforschung; 1976; 26(42):658-61. PubMed ID: 947327
[TBL] [Abstract][Full Text] [Related]
16. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL
J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
[TBL] [Abstract][Full Text] [Related]
17. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria.
Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T
J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064
[TBL] [Abstract][Full Text] [Related]
18. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
[TBL] [Abstract][Full Text] [Related]
19. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
Focht J; Klietmann W; Nösner K
Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
